surface localization of glucosylceramide during cryptococcus neoformans infection allows targeting as a potential antifungal表面的本地化葡糖神经酰胺在新型隐球菌感染允许目标作为一个潜在的抗真菌.pdfVIP

下载本文档

1
0
约9.13万字
约 13页
2017-09-12 发布于上海
举报
版权申诉

surface localization of glucosylceramide during cryptococcus neoformans infection allows targeting as a potential antifungal表面的本地化葡糖神经酰胺在新型隐球菌感染允许目标作为一个潜在的抗真菌.pdf

1、本文档共13页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

surface localization of glucosylceramide during cryptococcus neoformans infection allows targeting as a potential antifungal表面的本地化葡糖神经酰胺在新型隐球菌感染允许目标作为一个潜在的抗真菌

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal 1 1 1 5 5 1 Ryan Rhome , Arpita Singh , Talar Kechichian , Monica Drago , Giulia Morace , Chiara Luberto , Maurizio Del Poeta1,2,3,4* 1 Departments of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, United States of America, 2 Departments of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, United States of America, 3 Department of Craniofacial Biology, Medical University of South Carolina, Charleston, South Carolina, United States of America, 4 Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina, United States of America, 5 Dipartimento di Sanita’ Pubblica, Microbiologia-Virologia, Universita’ degli Studi di Milano, Milan, Italy Abstract Cryptococcus neoformans (Cn) is a significant human pathogen that, despite current treatments, continues to have a high morbidity rate especially in sub-Saharan Africa. The need for more tolerable and specific therapies has been clearly shown. In the search for novel drug targets, the gene for glucosylceramide synthase (GCS1) was deleted in Cn, resulting in a strain (Dgcs1) that does not produce glucosylceramide (GlcCer) and is avirulent in mouse models of infection. To understand the biology behind the connection between virulence and GlcCer, the production and localization of GlcCer must be characterized in conditions that are prohibitive to the growth of Dgcs1 (neutral pH and high CO2). These prohibitive conditions are physiologically similar to those found in the ex